One of the critical parts to improving patient engagement in the clinical trials is improving the informed consent process
This webinar recording explores the latest industry and regulatory developments relating to the use of eConsent in clinical trials and what sponsors and sites need to consider before they deploy this in clinical trials.
On-Demand Webinar Archive
To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.Access Webinar Archive
eConsent has the potential to transform the conventional informed consent approach in clinical trials in a truly patient- centric way, while enhancing the consenting process for all stakeholders involved. From reducing errors and the burden on site staff to improving the patient experience, eConsent can significantly impact a study.
Key insights include:
- Learn how to reduce barriers to participation for sites and patients
- Discover the advantages to sponsors and sites in ensuring compliance with the informed consent process
- Explore the current regulatory guidance and geographical differences
- Examine the latest TransCelerate eConsent landscaping findings
Dr. Caroline Forkin
Senior Director Medical Affairs of FIRECREST, ICON
Dr. Forkin has led the interactions with regulatory authorities and ethics committees/IRBs to inform and shape the development and roll-out of FIRECREST eConsent, since 2015. In this role, she has also commissioned research into the appropriate content and approach for conveying patient-appropriate information through a multi-media format for use in the consent process. Dr. Forkin is an active member of the ACRO Transcelerate eConsent working group.
Dr. Forkin has twenty two years’ experience as a physician, primarily in infectious diseases, including nine years in Mozambique working for the World Bank and Irish Aid in International Health. Prior to ICON, she held positions in the biotech pharmaceutical industry with Shire Pharmaceuticals and Amgen Pharmaceuticals in Ireland. She holds a Membership of the Royal College of Physicians of Ireland (MRCPI), an MBA in Healthcare Management, and Diplomas in Public Health and Pharmaceutical Medicine.
Register today to gain insights in eConsent: Better for the patient, Better for the site.